191 related articles for article (PubMed ID: 3544789)
1. Differences in cardiovascular profile among calcium antagonists.
Taira N
Am J Cardiol; 1987 Jan; 59(3):24B-29B. PubMed ID: 3544789
[TBL] [Abstract][Full Text] [Related]
2. Reconsideration of vascular selectivity of dihydropyridine calcium antagonists: comparison of cardiovascular profile of mepirodipine, a novel dihydropyridine consisting of a single stereoisomer with (+)-(S)-(S) conformation, with those of nifedipine and nicardipine.
Motomura S; Hashimoto K
Jpn J Pharmacol; 1990 Feb; 52(2):319-30. PubMed ID: 2313939
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of calcium antagonists.
Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
[TBL] [Abstract][Full Text] [Related]
5. Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists.
Nakaya H; Hattori Y; Nakao Y; Kanno M
Eur J Pharmacol; 1988 Jan; 146(1):35-43. PubMed ID: 3350058
[TBL] [Abstract][Full Text] [Related]
6. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
7. Effects of Bay k 8644 on the coronary vascular selectivity of the dihydropyridine Ca antagonists in the canine isolated, blood-perfused papillary muscle preparation.
Motomura S; Hashimoto K; Hashimoto K
J Cardiovasc Pharmacol; 1987 Dec; 10(6):627-35. PubMed ID: 2450231
[TBL] [Abstract][Full Text] [Related]
8. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
Schwinger RH; Böhm M; Erdmann E
Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
[TBL] [Abstract][Full Text] [Related]
9. Relative negative inotropic potencies of nine calcium channel blockers in cultured heart cells.
Briand V; Laurent S; Vaxelaire JF; Micheli L; Auclair MC; Schmitt H
Arch Int Pharmacodyn Ther; 1988; 295():125-37. PubMed ID: 3245728
[TBL] [Abstract][Full Text] [Related]
10. Cardiac versus coronary vasodilator actions of KB-944, a new calcium antagonist, assessed in isolated, blood-perfused heart preparations of dogs.
Taira N; Kawada M; Satoh K
J Cardiovasc Pharmacol; 1983; 5(3):349-56. PubMed ID: 6191131
[TBL] [Abstract][Full Text] [Related]
11. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
Wada Y; Satoh K; Taira N
J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
[TBL] [Abstract][Full Text] [Related]
12. Intervessel (arteries and veins) and heart/vessel selectivities of therapeutically used calcium entry blockers: variable, vessel-dependent indexes.
Magnon M; Gallix P; Cavero I
J Pharmacol Exp Ther; 1995 Dec; 275(3):1157-66. PubMed ID: 8531077
[TBL] [Abstract][Full Text] [Related]
13. Hydrophobic properties of novel dihydronaphthyridine calcium antagonists and biological activity in porcine isolated cardiac and vascular smooth muscle.
Werner G; Klaus W; Kojda G; Fricke U
Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):337-44. PubMed ID: 1961259
[TBL] [Abstract][Full Text] [Related]
14. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
Imagawa J; Satoh K; Taira N
Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
[TBL] [Abstract][Full Text] [Related]
15. Different negative inotropic activity of Ca2(+)-antagonists in human myocardial tissue.
Schwinger RH; Böhm M; Erdmann E
Klin Wochenschr; 1990 Aug; 68(16):797-805. PubMed ID: 2145465
[TBL] [Abstract][Full Text] [Related]
16. Second-generation calcium antagonists: search for greater selectivity and versatility.
Singh BN; Baky S; Nademanee K
Am J Cardiol; 1985 Jan; 55(3):214B-221B. PubMed ID: 3155893
[TBL] [Abstract][Full Text] [Related]
17. In-vitro negative chronotropic and inotropic effects of a novel dihydropyridine derivative, CD-832, in the guinea-pig: comparison with calcium-channel antagonists.
Noguchi K; Takahashi K; Higuchi S
J Pharm Pharmacol; 1998 Mar; 50(3):329-34. PubMed ID: 9600727
[TBL] [Abstract][Full Text] [Related]
18. Lacidipine, a new long-acting dihydropyridine calcium antagonist, has high vascular selectivity against all intracardiac variables.
Motomura S; Wu ZJ; Hashimoto K
Heart Vessels; 1993; 8(1):16-22. PubMed ID: 8454559
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cardiodepressant and vasodilator effects of PN 200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbits.
Hof RP
Am J Cardiol; 1987 Jan; 59(3):37B-42B. PubMed ID: 2949587
[TBL] [Abstract][Full Text] [Related]
20. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]